NEWRON PHARMACEUTICA

NWRN
Delayed Quote. Delayed  - 12/09 03:23:36 am
1.6CHF -0.62%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 35,427,5
Entreprise Value (EV)2 29,839,0
P/E ratio -1,68x-1,49x
Yield --
Capitalization / Revenue 6,73x4,92x
EV / Revenue 5,67x6,97x
EV / EBITDA -1,67x-2,48x
Price to Book 2,05x-
Nbr of stocks (in thousands) 17 84517 845
Reference price (EUR) 1,981,54
Announcement Date 03/16/2021-
Previous period Next period
1 CHF in Million
2 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 5,265,60
EBITDA1 -17,8-15,7
Operating profit (EBIT)1 -18,1-15,9
Operating Margin -344%-284%
Pre-Tax Profit (EBT)1 -19,6-18,5
Net income1 -21,0-18,4
Net margin -399%-330%
EPS2 -1,18-1,04
Dividend per Share2 --
Announcement Date 03/16/2021-
Previous period Next period
1 EUR in Million
2 EUR
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 -11,5
Net Cash position1 5,58-
Leverage (Debt / EBITDA) 0,31x-0,73x
Free Cash Flow -15,6-
ROE (Net Profit / Equities) --
Shareholders' equity1 --
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share 0,97-
Cash Flow per Share --
Capex1 0,030,11
Capex / Sales 0,65%2,01%
Announcement Date 03/16/2021-
Previous period Next period
1 EUR in Million
Financial Ratios
Size 2021e 2022e
Capitalization 28 M € -
Entreprise Value (EV) 39,0 M € 67,6 M €
Valuation 2021e 2022e
P/E ratio (Price / EPS) -1,49x -1,04x
Capitalization / Revenue 4,92x 4,22x
EV / Revenue 6,97x 5,98x
EV / EBITDA -2,48x -1,69x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -284% -357%
Operating Leverage (Delta EBIT / Delta Sales) 1,87x -
Net Margin (Net Profit / Revenue) -330% -405%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   2,01% 1,73%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -0,73x -1,74x
EPS & Dividend